Phil’s Journal: The Face of Alzheimer’s Is Changing — Are We Ready?
A few weeks ago, my husband Tim and I were sitting at our kitchen counter, chatting over dinner and looking through the day’s mail….
A few weeks ago, my husband Tim and I were sitting at our kitchen counter, chatting over dinner and looking through the day’s mail….
This Alzheimer’s drug has already been approved for use in China. The clinical trials that could lead to approval in the U.S. have just…
Retired Air Force engineer Chuck McClatchey, who was diagnosed with Alzheimer’s at the age of 61, shares his story. Desert Storm veteran Chuck McClatchey,…
UPDATE: 3 March 2024, 8:30 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Human clinical trials kick off for Protollin, an experimental Alzheimer’s vaccine. After two decades of research and development, Brigham and Women’s Hospital has initiated…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Dave Balbridge grew up in Los…
Inevitably, dementia affects a person’s identity, and it can take time to come to terms with some of the changes along the way. For…
Two years into the pandemic, researchers are still figuring out what’s going on inside the heads of COVID-19 survivors. From brain fog, to neurologically…
Trouble remembering things? Similar to Alzheimer’s, depression can cause memory loss. According to the World Health Organization, more than 280 million people worldwide live…
As we age, we experience an increased risk of developing high blood pressure or hypertension — the leading risk factor for disease in the world. Dementia…
A new study shows that individuals with a neurodegenerative language disorder called primary progressive aphasia (PPA) have Alzheimer’s-like plaques and tangles in their brains…
Brain cells from people with Alzheimer’s have a unique pattern of mutations, which may help explain why the cells begin to die. The genetic…
Breakthrough advancements in gene-sequencing technologies have opened up new pathways for understanding health and disease. Scientists can sequence our genetic code to search for…
Biogen CEO Michel Vounatsos will resign as the company begins to substantially reduce its infrastructure for producing Aduhelm. UPDATE: 3 March 2024, 8:37 P.M….
Cells called astrocytes use the protein encoded by ApoE4 — a genetic mutation linked to Alzheimer’s risk — to transport cholesterol in the brain….